首页> 美国卫生研究院文献>Breast Cancer : Targets and Therapy >Preexposure of MCF-7 breast cancer cell line to dexamethasone alters the cytotoxic effect of paclitaxel but not 5-fluorouracil or epirubicin chemotherapy
【2h】

Preexposure of MCF-7 breast cancer cell line to dexamethasone alters the cytotoxic effect of paclitaxel but not 5-fluorouracil or epirubicin chemotherapy

机译:MCF-7乳腺癌细胞系预先暴露于地塞米松可改变紫杉醇的细胞毒性作用但不能改变5-氟尿嘧啶或表柔比星化疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

PurposeGlucocorticoids (GCs) are often administered prior to any chemotherapeutics to prevent the secondary effects of anticancer agents. Glucocorticoid receptors (GRs) are expressed in several types of cancer cells, particularly in several histological types of breast cancer. Activation of GRs is not associated with any specific cellular response. Both proapoptotic and antiapoptotic responses have been observed, depending on the study or the type of breast cancer cells. Therefore, it is of relevance to investigate the possible modulation of apoptotic effect of chemotherapeutic agents when cancerous cells have previously been exposed to GCs.
机译:目的糖皮质激素(GCs)通常在任何化学治疗之前使用,以预防抗癌药的继发作用。糖皮质激素受体(GRs)在几种类型的癌细胞中表达,尤其是在几种组织学类型的乳腺癌中表达。 GR的激活与任何特定的细胞反应无关。已经观察到促凋亡和抗凋亡反应,这取决于研究或乳腺癌细胞的类型。因此,研究癌细胞先前已暴露于GC时化学治疗剂对细胞凋亡作用的可能调节具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号